ZANGANEH MAHKAM purchased 0.4% of their position (100K shares) of SUMMIT THERAPEUTICS INC. on the open market
Open‑market purchase worth $1.46M — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/4/2026ACC: 0001507650-26-000005
+100K
Net shares
Net buyer
$1.46M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+100K
Price / share
$14.60
Trade value
$1.46M
% of position
0.4%
6/4/2026
25.72M→25.82M
Total
Net shares
+100K
Net value
$1.46M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/4/2026 | P · Purchase | +100K | $14.60 | $1.46M | 0.4% | 25.72M | 25.82M |
| Total | +100K | $1.46M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned76.68K
Common Stock
IndirectShares owned10.20M
Common Stock
DirectShares owned31K
Common Stock
IndirectShares owned570.07M
Total
31K direct·580.35M indirect580.38M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 76.68K | Indirect |
| Common Stock | 10.20M | Indirect |
| Common Stock | 31K | Direct |
| Common Stock | 570.07M | Indirect |
| Total | 580.38M | 31K direct·580.35M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported